CoChat

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

Open access
Garg, Amit, Malviya, Neeta, Strunk, Andrew, Wright, Shari, Alavi, Afsaneh, Alhusayen, Raed, Alikhan, Ali, Daveluy, Steven D., Delorme, Isabelle, Goldfarb, Noah, Gulliver, Wayne, Hamzavi, Iltefat, Jaleel, Tarannum, Kimball, Alexa B., Kirby, Joslyn S., Kirchhof, Mark G., Lester, Janice, Lev-Tov, Hadar, Lowes, Michelle A., Micheletti, Robert, Orenstein, Lauren A., Piguet, Vincent, Sayed, Christopher, Tan, Jerry, Naik, Haley B. · 2022 · Journal of the American Academy of Dermatology
Cited by 239

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk. OBJECTIVE: To provide evidence-based screening recommendations for comorbidities linked to HS. METHODS: Systematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population. The screening recommendation for each comorbidity was informed by the consistency and quality of existing studies, disease prevalence, and magnitude of association, as well as benefits, harms, and feasibility of screening. The level of evidence and strength of corresponding screening recommendation were graded by using the Strength of Recommendation Taxonomy (SORT) criteria. RESULTS: Screening is recommended for the following comorbidities: acne, dissecting cellulitis of the scalp, pilonidal disease, pyoderma gangrenosum, depression, generalized anxiety disorder, suicide, smoking, substance use disorder, polycystic ovary syndrome, obesity, dyslipidemia, diabetes mellitus, metabolic syndrome, hypertension, cardiovascular disease, inflammatory bowel disease, spondyloarthritis, and sexual dysfunction. It is also recommended to screen patients with Down syndrome for HS. The decision to screen for specific comorbidities may vary with patient risk factors. The role of the dermatologist in screening varies according to comorbidity. LIMITATIONS: Screening recommendations represent one component of a comprehensive care strategy. CONCLUSIONS: Dermatologists should support screening efforts to identify comorbid conditions in HS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaad.2021.01.059

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Garg, A., Malviya, N., Strunk, A., Wright, S., Alavi, A., Alhusayen, R., Alikhan, A., Daveluy, S. D., Delorme, I., Goldfarb, N., Gulliver, W., Hamzavi, I., Jaleel, T., Kimball, A. B., Kirby, J. S., Kirchhof, M. G., Lester, J., Lev-Tov, H., Lowes, M. A., Micheletti, R., Orenstein, L. A., Piguet, V., Sayed, C., Tan, J., & Naik, H. B.
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
2022-05
Volume
86
Issue
5
Pages
1092-1101
ISSN
0190-9622 (ISSN-L)
OpenAlex
W3123328370
Cited by
239
References
6
FWCI
24.27
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.